As of 2025-05-17, the Intrinsic Value of Crown Electrokinetics Corp. (CRKN) is 110.77 USD. This CRKN valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 2.85 USD, the upside of Crown Electrokinetics Corp. is 3,786.50%.
The range of the Intrinsic Value is 36.54 - 177.95 USD
Based on its market price of 2.85 USD and our intrinsic valuation, Crown Electrokinetics Corp. (CRKN) is undervalued by 3,786.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (19,456.33) - (749.73) | (1,295.32) | -45549.8% |
| DCF (Growth 10y) | (542.08) - (9,068.08) | (803.05) | -28277.3% |
| DCF (EBITDA 5y) | 36.54 - 177.95 | 110.77 | 3786.5% |
| DCF (EBITDA 10y) | (79.59) - 168.40 | 30.44 | 968.0% |
| Fair Value | -159.59 - -159.59 | -159.59 | -5,699.60% |
| P/E | (273.22) - (355.56) | (327.16) | -11579.2% |
| EV/EBITDA | (151.79) - 66.81 | (51.13) | -1893.9% |
| EPV | (288.20) - (688.34) | (488.27) | -17232.4% |
| DDM - Stable | (621.61) - (18,490.92) | (9,556.27) | -335407.6% |
| DDM - Multi | (384.86) - (9,014.26) | (742.38) | -26148.3% |
| Market Cap (mil) | 2.73 |
| Beta | 2.40 |
| Outstanding shares (mil) | 0.96 |
| Enterprise Value (mil) | -10.05 |
| Market risk premium | 4.60% |
| Cost of Equity | 5.69% |
| Cost of Debt | 20.95% |
| WACC | 8.13% |